Clofibrate is the first fibrate lipid-lowering agent, now largely replaced by newer fibrates with more favourable safety profiles, retained as a reference compound for comparative fibrate pharmacology and legacy formulation support. Simson Pharma's Clofibrate reference standard supports these residual analytical needs.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Clofibrate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
